- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ChAd155-hIi-HBV low dose formulation
Total 284 results
-
GlaxoSmithKlineActive, not recruitingHepatitis B, ChronicTaiwan, Belgium, Thailand, Germany, Spain, Hong Kong, United Kingdom, France, Poland
-
Columbia UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
GlaxoSmithKlineTerminated
-
Themis Bioscience GmbHCompletedChikungunya Virus InfectionUnited Kingdom
-
Affiliated Hospital of Guangdong Medical UniversityNot yet recruiting
-
Boehringer IngelheimCompleted
-
Merck Sharp & Dohme LLCCompletedCervical Cancer | HPV | Premalignancy Anogenital Warts
-
GlaxoSmithKlineCompletedRespiratory Syncytial Virus InfectionsTaiwan, Spain, United States, Italy, Canada, Panama, Mexico, Poland
-
PfizerActive, not recruiting
-
Sanofi Pasteur, a Sanofi CompanyCompletedPneumonia | Pneumococcal Infections | Streptococcus Pneumoniae InfectionsBangladesh
-
GlaxoSmithKlineCompleted
-
Medicines Development for Global HealthImperial College London; Phillip T. and Susan M. Ragon FoundationTerminatedHIV InfectionsUnited Kingdom
-
Hookipa Biotech GmbHCentre for Vaccinology Ghent - CEVACCompletedCytomegalovirus InfectionBelgium
-
AstraZenecaCompletedUncontrolled and Persistent AsthmaUnited Kingdom
-
Idorsia Pharmaceuticals Ltd.CompletedSafety, Tolerability, Pharmacokinetics and PharmacodynamicsFrance
-
International AIDS Vaccine InitiativeGlaxoSmithKlineCompletedHIV InfectionsKenya, Zambia, Uganda
-
Boehringer IngelheimCompleted
-
NTC srlCompletedElective ColonoscopyFrance, Germany, Italy, Russian Federation
-
Mbarara University of Science and TechnologyThe Hospital for Sick ChildrenUnknownNeonatal Death | Birth AsphyxiaUganda
-
Boehringer IngelheimTerminated
-
BayerCompleted
-
Beijing Kawin Technology Share-Holding Co., Ltd.Completed
-
ViiV HealthcareGlaxoSmithKlineCompleted
-
ViiV HealthcareCompletedInfection, Human Immunodeficiency VirusUnited States
-
Boehringer IngelheimCompleted
-
Gilead SciencesNot yet recruiting
-
Ingredion IncorporatedCompleted
-
Institut PasteurCompleted
-
Merck Sharp & Dohme LLCCompleted
-
ViiV HealthcareCompleted
-
Boehringer IngelheimCompletedHIV InfectionsArgentina, Austria, Belgium, Brazil, Denmark, France, Germany, Greece, Ireland, Italy, Mexico, Netherlands, Portugal, Spain, Sweden, Switzerland, United Kingdom
-
ViiV HealthcareRecruiting
-
Onur Boyman, MDCompletedLupus Erythematosus, SystemicSwitzerland
-
Osel, Inc.University of California, San FranciscoCompletedBacterial VaginosisUnited States
-
Boehringer IngelheimCompleted
-
ViiV HealthcareCompletedInfection, Human Immunodeficiency VirusUnited States
-
Sirtris, a GSK CompanyCompleted
-
Merck Sharp & Dohme LLCTerminated
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
University of MiamiTerminatedHead and Neck Cancer | Recurrent Disease | Squamous Cell CarcinomaUnited States
-
Guangdong Raynovent Biotech Co., LtdCompletedCOVID-19 (Coronavirus Disease 2019)China
-
Boehringer IngelheimCompleted
-
Médecins du MondeUniversity of Bristol; PATH; UNITAID; Burnet Institute; Population Services International and other collaboratorsNot yet recruiting
-
Ian McGowanNational Institute of Allergy and Infectious Diseases (NIAID); CONRADCompletedHIV PreventionUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
PfizerNot yet recruitingHealthy Participants | Biological Availability
-
Boehringer IngelheimCompleted
-
The HIV Netherlands Australia Thailand Research...Ministry of Education, ThailandCompletedHIV Infections | HIV InfectionThailand